Q4 2021 Holdings
Filed 2022-02-14 | 25 holdings | $118.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $38.9M | 2,672,346 | 32.8% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $32.1M | 704,537 | 27.1% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $19.6M | 2,281,315 | 16.5% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $15.5M | 481,094 | 13.1% |
| Celcuity Inc(CELC) | COM | 15102K100 | $12.1M | 920,464 | 10.2% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $53.8K | 3,217,163 | 0.0% |
| Merus N V | COM | N5749R100 | $47.7K | 1,498,890 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $34.1K | 1,090,126 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $27.6K | 805,573 | 0.0% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $25.2K | 3,124,613 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $18.3K | 5,419,896 | 0.0% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $16.8K | 847,683 | 0.0% |
| Satsuma Pharmaceuticals Inc | COM | 80405P107 | $16.7K | 3,711,286 | 0.0% |
| Vistagen Therapeutics Inc(VTGNUSD) | COM NEW | 92840H202 | $16.5K | 8,464,999 | 0.0% |
| Tricida Inc(1T7) | COM | 89610F101 | $11.9K | 1,247,043 | 0.0% |
| Tenaya Therapeutics Inc(TNYA) | COM | 87990A106 | $9.7K | 513,930 | 0.0% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $8.0K | 815,667 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $4.1K | 312,553 | 0.0% |
| Kronos BIO Inc(KRON1USD) | COM | 50107A104 | $4.1K | 298,839 | 0.0% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $3.6K | 305,125 | 0.0% |
| Inventiva SA(IVA) | ADS | 46124U107 | $3.6K | 262,658 | 0.0% |
| Genocea Biosciences Inc(GNCAQ) | COM NEW | 372427401 | $3.6K | 3,079,756 | 0.0% |
| Mereo Biopharma Group PLC(MREO) | ADS | 589492107 | $3.1K | 1,954,970 | 0.0% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $2.9K | 125,000 | 0.0% |
| Bcls Acquisition Corp | COM CL A | G0904B105 | $2.5K | 250,000 | 0.0% |